Literature DB >> 20605932

Retrospective evaluation of cetuximab-related adverse events from claims databases--methodological concerns.

S Maier1, G Peltz2, J R Penrod3, K P Sugarman4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20605932     DOI： 10.1093/annonc/mdq327

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  2 in total

Review 1.  Epidermal growth factor receptor and metastatic colorectal cancer: insights into target therapies.

Authors:  Ramon Andrade de Mello; Andrea Marin Marques; António Araújo
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

2.  Nimotuzumab in combination with radiotherapy in high grade glioma patients: a single institution experience.

Authors:  Maria Teresa Solomon; Nederlay Miranda; Eugenia Jorrín; Ivonne Chon; Jorge Juan Marinello; José Alert; Patricia Lorenzo-Luaces; Tania Crombet
Journal:  Cancer Biol Ther       Date:  2014-02-12       Impact factor: 4.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.